Cardea Bio, an EvoNexus portfolio company, receives Gates Foundation funding to develop electronic nose to rapidly diagnose infectious diseases via breath
May 03, 2022, 09:00 ET SAN DIEGO, May 3, 2022 /PRNewswire/ — Today, Cardea Bio, Inc. – the world’s only mass producer of biocompatible semiconductors – announced that it has been awarded a $1.1 […]